Provided by Tiger Trade Technology Pte. Ltd.

Insulet

224.70
+4.862.21%
Volume:677.59K
Turnover:153.36M
Market Cap:15.81B
PE:64.59
High:229.89
Open:222.80
Low:219.89
Close:219.84
52wk High:354.88
52wk Low:216.49
Shares:70.35M
Float Shares:70.08M
Volume Ratio:0.66
T/O Rate:0.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.48
EPS(LYR):3.48
ROE:18.12%
ROA:9.43%
PB:10.43
PE(LYR):64.59

Loading ...

Insulet: Strong Q4 Execution and Encouraging 2026 Outlook Offset by Valuation and Competitive Pressures, Justifying Hold Rating

TIPRANKS
·
Feb 19

Insulet: Sustained Growth Runway and Underappreciated Long‑Term Upside Support Buy Rating

TIPRANKS
·
Feb 19

Insulet Price Target Maintained With a $380.00/Share by BTIG

Dow Jones
·
Feb 19

Early notable gainers among liquid option names on February 18th

TIPRANKS
·
Feb 18

Stock Track | Insulet Soars 9.57% Intraday on Strong Q4 Earnings Beat, Robust Omnipod Demand and Upbeat Guidance

Stock Track
·
Feb 18

Insulet Shares up 10% After Q4 Results Beat

THOMSON REUTERS
·
Feb 18

BUZZ-Insulet climbs on better-than-expected quarterly results

Reuters
·
Feb 18

Insulet Shares up 8% Premarket After Q4 Results Beat

THOMSON REUTERS
·
Feb 18

Stock Track | Insulet Soars 5.14% in Pre-market on Strong Q4 Results, Robust Guidance and Share Buyback Plan

Stock Track
·
Feb 18

Insulet beats quarterly estimates on strong demand for wearable insulin pumps

Reuters
·
Feb 18

Insulet Q4 revenue beats on Omnipod strength

Reuters
·
Feb 18

Insulet Publishes Corporate Presentation on Omnipod Growth, AID Leadership, and Product Pipeline

Reuters
·
Feb 18

Insulet Q4 Adj. EPS $1.55 Beats $1.45 Estimate, Sales $783.800M Beat $768.691M Estimate

Benzinga
·
Feb 18

BRIEF-Insulet Q4 Revenue USD 783.8 Million Vs. IBES Estimate USD 768.7 Million

Reuters
·
Feb 18

Insulet Reports Fourth Quarter and Full Year 2025 Results

THOMSON REUTERS
·
Feb 18

Insulet Corp - Plans to Allocate Approximately $300 Million Toward Repurchases in the First Quarter of 2026

THOMSON REUTERS
·
Feb 18

Insulet Outlook FY 2026 Adj EPS Growth of More Than 25%

THOMSON REUTERS
·
Feb 18

Insulet Outlook Q1 Revenue Growth 25-27%

THOMSON REUTERS
·
Feb 18

Insulet Outlook FY 2026 Revenue Growth 20% - 22%

THOMSON REUTERS
·
Feb 18

U.S. Earnings Preview: Before Market Open Feb. 18

Dow Jones
·
Feb 18